在常见的眼科疾病中使用系统性碳酸无水酶抑制剂:从临床角度进行范围审查
Shahin Hallaj1,2, Wesam Shamseldin Shalaby1,3, Sapna Sinha1
1Glaucoma Service, Wills Eye Hospital, Sidney Kimmel Medical College, Thomas Jefferson University, 840 Walnut St, Suite 1140, Philadelphia, PA 19107 USA.
Current ophthalmology reports
|July 11, 2025
概括
系统性碳酸酶抑制剂 (CAI) 有效地管理眼科疾病,如玻璃眼瘤. 尽管有潜在的副作用,但严重的不良事件很少发生,当风险被仔细管理时,这使得它们成为有价值的治疗选择.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 系统性碳酸酶抑制剂 (CAI) 对于治疗眼科疾病,如玻璃眼瘤至关重要.
- 由于担心严重的系统性不良影响,通常会限制它们的临床使用.
- 最近的研究澄清了碳酸酶 (CA) 异酶和系统CAI机制的作用.
研究的目的:
- 提供眼科护理中系统性CAI的全面审查.
- 检查系统性CAI的药理学,药理动力学,安全性和适用性.
- 要突出策略,以减轻伴随疾病患者的治疗挑战.
主要方法:
- 对系统性碳酸酶抑制剂的文献综述.
- 对药理学,药理动力学和安全性概况的分析.
- 对临床症状和治疗策略的评估.
主要成果:
- 酸盐异酶 (CA-II,CA-IV) 在水性幽默的产生和眼部血流中起着关键作用.
- 最大的眼内压力降低取决于与组织结合的药物度.
- 严重的全身性不良事件很少发生,即使在患有并发症的患者中也是如此.
结论:
- 系统性CAI对于在特定的眼部疾病中维护视力至关重要.
- 系统性CAI严重不良事件的发生率很低,与局部治疗相比.
- 个人风险益处评估和正确使用对于安全有效的治疗至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
583
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
583
Angle Closure Glaucoma: Treatment
702
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
702
Glaucoma: Overview
777
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
777
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
893
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
893
Direct-Acting Cholinergic Agonists: Therapeutic Uses
904
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
904


